ARCT-165
ARCT-165-01
Phase 2 mab completed
Quick answer
ARCT-165 for COVID-19 is a Phase 2 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- mab
- Status
- completed